Skip to Content
Merck
CN
  • Bacterial drug tolerance under clinical conditions is governed by anaerobic adaptation but not anaerobic respiration.

Bacterial drug tolerance under clinical conditions is governed by anaerobic adaptation but not anaerobic respiration.

Antimicrobial agents and chemotherapy (2014-07-23)
Claudia M Hemsley, Jamie X Luo, Clio A Andreae, Clive S Butler, Orkun S Soyer, Richard W Titball
ABSTRACT

Noninherited antibiotic resistance is a phenomenon whereby a subpopulation of genetically identical bacteria displays phenotypic tolerance to antibiotics. We show here that compared to Escherichia coli, the clinically relevant genus Burkholderia displays much higher levels of cells that tolerate ceftazidime. By measuring the dynamics of the formation of drug-tolerant cells under conditions that mimic in vivo infections, we show that in Burkholderia bacteria, oxygen levels affect the formation of these cells. The drug-tolerant cells are characterized by an anaerobic metabolic signature and can be eliminated by oxygenating the system or adding nitrate. The transcriptome profile suggests that these cells are not dormant persister cells and are likely to be drug tolerant as a consequence of the upregulation of anaerobic nitrate respiration, efflux pumps, β-lactamases, and stress response proteins. These findings have important implications for the treatment of chronic bacterial infections and the methodologies and conditions that are used to study drug-tolerant and persister cells in vitro.

MATERIALS
Product Number
Brand
Product Description

Supelco
Metronidazole, Pharmaceutical Secondary Standard; Certified Reference Material
Metronidazole, European Pharmacopoeia (EP) Reference Standard
Supelco
Metronidazole, analytical standard
Sigma-Aldrich
Metronidazole, BioXtra
Supelco
Metronidazole, VETRANAL®, analytical standard
Supelco
Phenol solution, 5000 μg/mL in methanol, certified reference material
Supelco
Phenol solution, certified reference material, 500 μg/mL in methanol
Sigma-Aldrich
Liquified Phenol, ≥89.0%
Supelco
Phenol solution, 100 μg/mL in acetonitrile, PESTANAL®, analytical standard
Sigma-Aldrich
Phenol solution, Saturated with 0.01 M citrate buffer, pH 4.3 ± 0.2, BioReagent, Molecular Biology
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
USP
Phenol, United States Pharmacopeia (USP) Reference Standard
Supelco
Phenol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Phenol solution, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, BioReagent, Molecular Biology
Supelco
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Phenol, ≥99%
Sigma-Aldrich
Phenol, ACS reagent, ≥99.0%
Sigma-Aldrich
Phenol, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
Sigma-Aldrich
Phenol, puriss., ≥99.5% (GC), meets analytical specification of Ph. Eur., BP, USP, crystalline (detached)
Sigma-Aldrich
Phenol, ≥96.0% (calc. on dry substance, T)
Sigma-Aldrich
Phenol, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC)
Supelco
Phenol, PESTANAL®, analytical standard
Sigma-Aldrich
Phenol, unstabilized, ReagentPlus®, ≥99%
Sigma-Aldrich
Phenol, unstabilized, purified by redistillation, ≥99%
Sigma-Aldrich
Phenol, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Phenol, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
Phenol, Molecular Biology
Sigma-Aldrich
Phenol, BioUltra, Molecular Biology, TE-saturated, ~73% (T)